Issues related to neglected diseases research and development, access, and drug pricing; COVID treatments research and development.
FY 2022 and FY 2023 State and Foreign Operations funding for global health research and development and neglected tropical diseases and covid treatments; Issues related to global health.
Duration: October 1, 2009
to
January 14, 2022
General Issues: Medical/Disease Research/Clinical Labs , Budget/Appropriations , Foreign Relations , Health Issues
Spending: about $490,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), State - Dept of (DOS), House of Representatives,, U.S. Senate,, Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2022
Faegre Drinker Biddle & Reath LLP terminated an engagement in which they represented Drugs for Neglected Diseases Initiative of North America on April 15, 2022.
Original Filing: 301356536.xml
Lobbying Issues
Issues related to neglected diseases research and development, access, and drug pricing; COVID treatments research and development.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY 2022 and FY 2023 State and Foreign Operations funding for global health research and development and neglected tropical diseases and covid treatments; Issues related to global health.
4th Quarter, 2021
In Q4, Faegre Drinker Biddle & Reath LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 11, 2022.
Original Filing: 301321113.xml
Lobbying Issues
Issues related to neglected diseases research and development, access, and drug pricing; COVID treatments research and development.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY 2022 and FY 2023 State and Foreign Operations funding for global health research and development and neglected tropical diseases and covid treatments; Issues related to global health.
3rd Quarter, 2021
In Q3, Faegre Drinker Biddle & Reath LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305906.xml
Lobbying Issues
Issues related to neglected diseases research and development, access, and drug pricing; Global health equity; COVID treatments research and development.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY 2022 and FY 2023 State and Foreign Operations funding for global health research and development and neglected tropical diseases; Issues related to global health.
2nd Quarter, 2021
In Q2, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 19, 2021.
Original Filing: 301281902.xml
Lobbying Issues
Issues related to neglected diseases research and development, access, and drug pricing; Global health equity; COVID treatments research and development.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY 2022 State and Foreign Operations funding for global health research and development; Issues related to global health.
1st Quarter, 2021
In Q1, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 20, 2021.
Original Filing: 301260585.xml
Lobbying Issues
Issues related to neglected diseases research and development, access, and drug pricing; global health equity; COVID treatments research and development.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
FY 22 State and Foreign Operations funding for global health research and development; Issues related to global health.
4th Quarter, 2020
In Q4, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 15, 2021.
Original Filing: 301232315.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases; Drug pricing; Research and development.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Consolidated Appropriations Act, 2021; Issues related to global health and antibiotic research and development.
3rd Quarter, 2020
In Q3, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 17, 2020.
Original Filing: 301212500.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 17, 2020.
Original Filing: 301190804.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases; CURES 2.0 legislative initiative; Access and affordability of COVID-19 treatments and vaccines; Draft PASTEUR Act legislation.
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, Faegre Drinker Biddle & Reath LLP (Formerly Known As Drinker Biddle & Reath LLP) lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 17, 2020.
Original Filing: 301169683.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108613.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 14, 2019.
Original Filing: 301065060.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases; H.R.3460 - End Neglected Tropical Diseases Act.
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2019
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 16, 2019.
Original Filing: 301046169.xml
Lobbying Issues
Issues related to anti-microbial resistance and neglected tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2019
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 4, 2019.
Original Filing: 301022719.xml
Lobbying Issues
Neglected Tropical Disease Research and Development; H.R. 6378, Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act.
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2018
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 14, 2019.
Original Filing: 301004192.xml
Lobbying Issues
Neglected Tropical Disease Research and Development; H.R. 6378, Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act.
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2018
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 12, 2018.
Original Filing: 300984802.xml
Lobbying Issues
FY 2019 State and Foreign Operation Appropriation Bill (S. 3108, House Draft); Provisions related to neglected tropical disease research and development; FY 2019 funding for neglected tropical disease research and development; FY 2019 Funding for antimicrobial resistance and research and development; FY 2019 Labor, Health and Human Services & Education appropriations bill (S. 3158, House Draft).
Lobbying Issues
Neglected Tropical Disease Research and Development; H.R. 6378, Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act.
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2018
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 12, 2018.
Original Filing: 300964128.xml
Lobbying Issues
FY 2019 State and Foreign Operation Appropriation Bill (S. 3108, House Draft); Provisions related to neglected tropical disease research and development; FY 2019 funding for neglected tropical disease research and development; FY 2019 Funding for antimicrobial resistance and research and development; FY 2019 Labor, Health and Human Services & Education appropriations bill (S. 3158, House Draft).
Lobbying Issues
Neglected Tropical Disease Research and Development; Draft House Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act.
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2018
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 18, 2018.
Original Filing: 300946931.xml
Lobbying Issues
FY 2019 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2019 funding for neglected tropical disease research and development; FY 2019 Funding for antimicrobial resistance and research and development; FY 2019 Labor, Health and Human Services & Education appropriations bill; H.R. 1625, Consolidated Appropriations Act of 2018.
Lobbying Issues
Neglected Tropical Disease Research and Development; HR 1415 End Neglected Disease Act; Draft NTD legislation.
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2017
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 10, 2018.
Original Filing: 300922349.xml
Lobbying Issues
FY 2018 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2018 funding for neglected tropical disease research and development; FY 18 Funding for antimicrobial resistance and research and development; FY 18 Labor, Health and Human Services & Education appropriations bill; FY 19 funding for Neglected Tropical Diseases Program and Research and Development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Neglected Tropical Disease Research and Development; HR 1415 End Neglected Disease Act.
Agencies Lobbied
U.S. Senate Centers For Disease Control & Prevention (CDC) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2017
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 17, 2017.
Original Filing: 300905741.xml
Lobbying Issues
FY 2018 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2018 funding for neglected tropical disease research and development; FY 18 Funding for antimicrobial resistance and research and development; FY 18 Labor, Health and Human Services & Education appropriations bill; FY 19 funding for Neglected Tropical Diseases Program and Research and Development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Issues related to priority review voucher for tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2017
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 20, 2017.
Original Filing: 300892550.xml
Lobbying Issues
FY 2018 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2018 funding for neglected tropical disease research and development; FY 18 Funding for antimicrobial resistance and research and development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to priority review voucher for tropical diseases; H.R. 1415 End Neglected Tropical Diseases Act; Draft legislation on domestic neglected tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2017
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 20, 2017.
Original Filing: 300875471.xml
Lobbying Issues
S. 3117 and House draft FY 2017 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2018 funding for neglected tropical disease research and development; FY 18 Funding for antimicrobial resistance and research and development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to priority review voucher for tropical diseases; H.R. 1415 End Neglected Tropical Diseases Act; H.R. 749 The Lower Cost Through Competition Act, provisions related to priority review vouchers.
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2016
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 18, 2017.
Original Filing: 300848507.xml
Lobbying Issues
S. 3117 and House draft FY 2017 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2018 funding for neglected tropical disease research and development.
Lobbying Issues
Issues related to priority review voucher for tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2016
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 13, 2016.
Original Filing: 300827364.xml
Lobbying Issues
S. 3117 and House draft FY 2017 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development; FY 2018 funding for neglected tropical disease research and development.
Agencies Lobbied
Office of Management & Budget (OMB)
Lobbying Issues
Issues related to priority review voucher for tropical diseases.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2016
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 12, 2016.
Original Filing: 300808391.xml
Lobbying Issues
S. 3117 and House draft FY 2017 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development.
Lobbying Issues
Issues related to priority review voucher for tropical diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2016
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 15, 2016.
Original Filing: 300791795.xml
Lobbying Issues
FY 2017 State and Foreign Operation Appropriation Bill; Provisions related to neglected tropical disease research and development.
Lobbying Issues
Issues related to priority review voucher for tropical diseases; H.R. 1797, End Neglected Tropical Disease Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2015
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 13, 2016.
Original Filing: 300771232.xml
Lobbying Issues
HR 2722/S. 1725 - FY 2016 State and Foreign Operation Appropriation Bill; FY 2017 Budget - provisions related to neglected tropical disease research and development.
Lobbying Issues
Issues related to priority review voucher for tropical diseases.
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2015
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 19, 2015.
Original Filing: 300756341.xml
Lobbying Issues
HR 2722/S. 1725 - FY 2016 State and Foreign Operation Appropriation Bill; FY 2017 Budget - provisions related to neglected tropical disease research and development.
Agencies Lobbied
Office of Management & Budget (OMB)
Lobbying Issues
HR 1797 - End Neglected Diseases Act; HR 2241 - Global Health Innovation Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 16, 2015.
Original Filing: 300736981.xml
Lobbying Issues
HR 2722/S. 1725 - FY 2016 State and Foreign Operation Appropriation Bill; S. 1695/House draft - Fiscal Year 2016 Labor, Health and Human Services and Education Appropriations Bill - provisions related to neglected tropical disease research and development.
Lobbying Issues
Issues related to FDA priority review voucher and other drug development incentives; H.R. 6 - 21st Century Cures Act, provisions related to priority review vouchers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
HR 1797 - End Neglected Diseases Act; HR 2241 - Global Health Innovation Act; Global Health Assembly agenda - provisions related to neglected diseases.
Agencies Lobbied
U.S. House of Representatives Health & Human Services - Dept of (HHS)
1st Quarter, 2015
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 15, 2015.
Original Filing: 300715917.xml
Lobbying Issues
FY 2016 State and Foreign Operation Appropriations and 2016 Senate Labor, Health and Human Services and Education Appropriations Bill - provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FDA priority review voucher and other drug development incentives; 21st Century Cures draft, provisions related to priority review vouchers.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2014
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 14, 2015.
Original Filing: 300695644.xml
Lobbying Issues
H.R. 83, FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act, issues related to FY 2015 State and Foreign Operation Appropriations and 2015 Senate Labor, Health and Human Services and Education Appropriations Bill - provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to FDA priority review voucher and other drug development incentives.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. 2917, Adding Ebola to the FDA Priority Review Voucher Program Act; Issues related to neglected tropical disease research; H.R. 4847, End Neglected Tropical Disease Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2014
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 17, 2014.
Original Filing: 300680012.xml
Lobbying Issues
H.R. 2855/S. 1283, FY 2015 State and Foreign Operation Appropriations and S. 1284 FY 2015 Senate Labor, Health and Human Services and Education Appropriations Bill - provisions related to neglected tropical disease and pediatric HIV/AIDS research and development, FY 2016 global health program funding.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB) State - Dept of (DOS)
Lobbying Issues
Issues related to FDA priority review voucher and other drug development incentives.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to neglected tropical disease research; 21st Century Cures Initiative; H.R. 4847, End Neglected Tropical Diseases Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2014
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 18, 2014.
Original Filing: 300662330.xml
Lobbying Issues
HR 2855/S. 1283, FY 2015 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to neglected tropical disease research; potential legislation related to neglected tropical diseases research, 21st Century Cures Initiative, HR 4944, Neglaected Infections of Impoverished Americans Act of 2014, HR 4847, End Neglected Tropical Diseases Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2014
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 15, 2014.
Original Filing: 300635766.xml
Lobbying Issues
FY 2015 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to neglected tropical disease research; potential legislation related to neglected tropical diseases research.
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2013
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 20, 2014.
Original Filing: 300621715.xml
Lobbying Issues
FY 2014 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development
Lobbying Issues
21st Century Global Health Technology Act (H.R. 1515); Issues related to neglected tropical disease research.
Agencies Lobbied
U.S. House of Representatives,
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2013
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 18, 2013.
Original Filing: 300599111.xml
Lobbying Issues
FY 2014 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
21st Century Global Health Technology Act (H.R. 1515); Issues related to neglected tropical disease research.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2013
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 19, 2013.
Original Filing: 300578608.xml
Lobbying Issues
FY 2014 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
21st Century Global Health Technology Act (H.R. 1515)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2013
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 22, 2013.
Original Filing: 300562152.xml
Lobbying Issues
FY 2013 and FY 2014 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development (H.R. 5857/S.3241/H.R. 933); 21st Century Global Health Technology Act - draft bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate Natl Institutes of Health (NIH)
4th Quarter, 2012
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 22, 2013.
Original Filing: 300539956.xml
Lobbying Issues
FY 2013 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development (H.R. 5857/S.3241).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300509729.xml
Lobbying Issues
FY 2013 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development (H.R. 5857/S.3241).
Agencies Lobbied
U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development; H.R. 6138 - Ending HIV/AIDS Epidemic Act of 2012.
Agencies Lobbied
U.S. House of Representatives,
2nd Quarter, 2012
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 19, 2012.
Original Filing: 300490728.xml
Lobbying Issues
FY 2013 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development (H.R. 5857/S.3241).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious and Pediatric HIV/AIDS Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2012
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 17, 2012.
Original Filing: 300462600.xml
Lobbying Issues
FY 2013 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious and Pediatric HIV/AIDS Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2011
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 18, 2012.
Original Filing: 300440987.xml
Lobbying Issues
FY 2012 and FY 2013 State and Foreign Operation Appropriations and provisions related to neglected tropical disease and pediatric HIV/AIDS research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious and Pediatric HIV/AIDS Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2011
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 17, 2011.
Original Filing: 300415900.xml
Lobbying Issues
FY 2011 and FY 2012 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2011
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 19, 2011.
Original Filing: 300397774.xml
Lobbying Issues
FY 2011 and FY 2012 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 14, 2011.
Original Filing: 300364352.xml
Lobbying Issues
FY 2011 and FY 2012 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 18, 2011.
Original Filing: 300342243.xml
Lobbying Issues
FY2011 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 5986 - Neglected Infections of Impoverished Americans Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2010
In Q3, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Oct. 18, 2010.
Original Filing: 300316679.xml
Lobbying Issues
FY2011 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 5986 - Neglected Infections of Impoverished Americans Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2010
In Q2, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on July 19, 2010.
Original Filing: 300294699.xml
Lobbying Issues
FY2011 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2010
In Q1, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on April 19, 2010.
Original Filing: 300264915.xml
Lobbying Issues
FY2011 State and Foreign Operation Appropriations and provisions related to neglected tropical disease research and development.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2009
In Q4, DRINKER BIDDLE & REATH LLP lobbied for Drugs for Neglected Diseases Initiative of North America , earning $10,000. The report was filed on Jan. 18, 2010.
Original Filing: 300234908.xml
Lobbying Issues
FY2011 State and Foreign Operation Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Provisions Related to Foreign Assistance Reform and Global Health Research and Development.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Health and Medical Research Programs for Neglected and Infectious Diseases.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2009
DRINKER BIDDLE & REATH LLP filed a lobbying registration on Oct. 5, 2009 to represent Drugs for Neglected Diseases Initiative of North America, effective Oct. 1, 2009.
Original Filing: 300201137.xml
Issue(s) they said they’d lobby about: Funding of research and development related to neglected diseases. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate